English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Regeneron Pharmaceuticals
Press release submission
| Jan 2, 2021
REGENERON: Announces Encouraging Initial Data from COVID-19 Antibody Cocktail Trial in Hospitalized Patients on Low-flow Oxygen
Press release submission
| Jul 5, 2020
Regeneron and Sanofi Provide Update on Kevzara® (sarilumab) Phase 3 U.S. Trial in COVID-19 Patients
Carol Ostrow
| Sep 23, 2017
Study shows Dupixent reduces symptoms of atopic dermatitis
Ruth de Jauregui
| May 7, 2017
Survey finds majority of rheumatoid arthritis patients living in pain
Ruth de Jauregui
| Apr 2, 2017
FDA approves Dupixent for atopic dermatitis
Trending
Patient Daily
| Sep 3, 2025
Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+
Pharmaceuticals
Patient Daily
| Sep 4, 2025
PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+
Pharmaceuticals
Patient Daily
| Aug 29, 2025
Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’
+
Pharmaceuticals
Patient Daily
| Sep 2, 2025
Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’
